BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6089102)

  • 1. Heparin-protein C interaction.
    Comp PC
    Nouv Rev Fr Hematol (1978); 1984; 26(4):239-42. PubMed ID: 6089102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein C.
    Esmon CT
    Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protein C, protein S and heparin cofactor II--their significance as the regulatory factors in the blood coagulation cascade].
    Shinmyozu K
    Rinsho Byori; 1994 Jan; 42(1):9-15. PubMed ID: 8107289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protein C: mechanisms of activation and anticoagulant effect].
    Kogan AE; Strukova SM
    Biokhimiia; 1993 Jun; 58(6):827-44. PubMed ID: 8364108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and the activated protein C anticoagulant pathway.
    Esmon CT
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():49-60. PubMed ID: 16673266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.
    Mosnier LO; Elisen MG; Bouma BN; Meijers JC
    Thromb Haemost; 2001 Oct; 86(4):1057-64. PubMed ID: 11686324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An antifibrinolytic effect associated with an anti-factor V antibody in a patient with severe thrombophilia.
    Colucci M; Simioni P; Piro D; Prandoni P; Pagnan A; Semeraro N
    Haematologica; 2003 Dec; 88(12):1383-9. PubMed ID: 14687992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis.
    Mosnier LO; Meijers JC; Bouma BN
    Thromb Haemost; 2001 Oct; 86(4):1040-6. PubMed ID: 11686322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor--no evidence for a cofactor role of protein S.
    de Fouw NJ; de Jong YF; Haverkate F; Bertina RM
    Thromb Haemost; 1988 Oct; 60(2):328-33. PubMed ID: 2975409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
    Delvos U; Meusel P; Preissner KT; Müller-Berghaus G
    Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex.
    Fuentes-Prior P; Iwanaga Y; Huber R; Pagila R; Rumennik G; Seto M; Morser J; Light DR; Bode W
    Nature; 2000 Mar; 404(6777):518-25. PubMed ID: 10761923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin.
    Colucci M; Pentimone A; Binetti BM; Cramarossa M; Piro D; Semeraro N
    Thromb Haemost; 2002 Aug; 88(2):282-7. PubMed ID: 12195701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of protein C activation on blood coagulation and fibrinolysis in squirrel monkeys.
    Colucci M; Stassen JM; Collen D
    J Clin Invest; 1984 Jul; 74(1):200-4. PubMed ID: 6547456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1.
    Keller TT; van der Sluijs KF; de Kruif MD; Gerdes VE; Meijers JC; Florquin S; van der Poll T; van Gorp EC; Brandjes DP; Büller HR; Levi M
    Circ Res; 2006 Nov; 99(11):1261-9. PubMed ID: 17068293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin.
    Mosnier LO; Meijers JC; Bouma BN
    Thromb Haemost; 2001 Jan; 85(1):5-11. PubMed ID: 11204587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thrombin-dependent activation of plasma procarboxypeptidase B.
    Hosaka Y; Takahashi Y; Ishii H
    Thromb Haemost; 1998 Feb; 79(2):371-7. PubMed ID: 9493593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
    Nakamura R; Umemura K; Hashimmoto H; Urano T
    Thromb Haemost; 2006 Apr; 95(4):637-42. PubMed ID: 16601834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protein C, protein S].
    Guillin MC; Bezeaud A
    Ann Biol Clin (Paris); 1987; 45(2):184-90. PubMed ID: 3039876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing protein C interaction with thrombin results in a clot-activated anticoagulant.
    Richardson MA; Gerlitz B; Grinnell BW
    Nature; 1992 Nov; 360(6401):261-4. PubMed ID: 1436107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The numerous properties of the anticoagulant protein C].
    Cerchiara E; Tirindelli MC; Giannetti B; Dicuonzo G; Avvisati G
    Clin Ter; 2007; 158(2):181-7. PubMed ID: 17566522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.